No red flags identified.
AI Transparency Report
Cancer Support Team Inc demonstrates a generally healthy financial position with consistent revenue growth and increasing assets over the past several years. For instance, revenue grew from $928,645 in 2020 to $1,699,685 in 2023, and assets increased from $2,002,423 to $3,119,590 in the same period. The organization consistently spends less than its revenue, leading to a healthy accumulation of assets, which suggests good financial management and sustainability. Their liabilities are also relatively low compared to their assets, indicating a strong balance sheet.
Regarding spending efficiency, the organization's expenses have generally been well below its revenue, allowing for asset growth. While specific program, administrative, and fundraising expense breakdowns are not provided in the summary data, the overall financial health suggests that the organization is managing its resources effectively. The absence of reported officer compensation is a notable aspect, indicating that leadership is either volunteer-based or compensated through other means not categorized as officer compensation, which can be a positive sign for donor confidence.
Transparency appears to be strong given the consistent filing of IRS Form 990s, with 13 filings available. The consistent growth in assets and revenue, coupled with controlled expenses, points to a well-managed and financially stable organization. The lack of officer compensation further enhances the perception of efficient resource allocation, as a significant portion of funds is not diverted to high executive salaries.